By: Frank Angst In a presentation at the Association of Racing Commissioners International conference March 23 in New Orleans, Jockey Club executive director Matt Iuliano highlighted studies examining the efficacy of administering furosemide at least 24 hours before a race. RCI president Ed Martin noted that some conference presentations will allow member commissioners to see
As part of its strategic initiative to protect the health and welfare of the racehorse, the American Association of Equine Practitioners has released a list of research topics identified by an expert panel as central to the goal of understanding exercise-induced pulmonary hemorrhage. The identified topics will help determine future research priorities in the investigation
Kentucky Attorney General Jack Conway has found unconstitutional a Kentucky Horse Racing Commission regulation that permits racetracks to conduct races for which horses could not be treated with the legal anti-bleeder medication furosemide, according to a release Wednesday from the Kentucky Horsemen’s Benevolent and Protective Association. Agreeing with the position of the Kentucky HPBA, Conway’s
By Jeremy Balan Nearly a month after the California Horse Racing Board hit the brakes on third-party administration of furosemide in the state, the governing body spent just more than a minute to move the process along at a meeting Sept. 16 at Los Alamitos Race Course. The CHRB approved a motion to send the
By Blood-Horse Staff Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15. The studies will examine the pathophysiology of EIPH, or bleeding in horses' lungs. The condition is currently treated with furosemide, also known
By Ron Mitchell The Administrative Regulation Review Subcommittee of the Kentucky legislature has voted 6-2 to find a proposed regulation permitting racetracks the option of carding furosemide-free races "deficient." Furosemide, commonly known as Salix or Lasix, is a widely-used anti-diuretic medication. In a release, the Kentucky Horsemen's Benevolent and Protective Association said the 6-2 vote
By Jeremy Balan The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding the potential employment of third-party furosemide administration in the state, but any change in procedures still likely won't occur until 2016. After the CHRB sent a proposal on third-party administration of furosemide, commonly known as
By Tom LaMarra The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks. The board of directors met Aug. 29 and approved the measure, the CTT said in a release. The organization also said it supports third-party
By Tom LaMarra In March 2013 eight states in the Mid-Atlantic and Northeast—Delaware, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Virginia, and West Virginia—announced their intentions to adopt uniform regulations governing equine medication rules and drug testing. The effort, spearheaded by the Thoroughbred Horsemen's Association, which represents owners and trainers in many states in the
By Edited Press Release Members of the California Horse Racing Board (CHRB) and California horse racing industry leaders are reaffirming their support for the concept of third-party furosemide (also called Salix or Lasix) administration as part of the National Uniform Medication Program, while offering reassurance that a vote by the board on Aug. 20 to
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
